Health Care Equipment & Services

Health Catalyst’s insider buying shows confidence amid low prices, suggesting a possible rebound if the company expands its data‑analytics platform beyond Utah.

Insider trades by IDEXX EVP Erickson show strategic buying low, selling high, reinforcing bullish sentiment and confidence in the company’s growth.

Insider buying sparks debate: CFO’s 8‑k‑share purchase amid NRCH’s slide shows mixed signals—investors should weigh timing, volume, and market trend.

Mark David’s recent 77‑share buy at $18.47 shows executive confidence in Tandem Diabetes Care’s future despite a 40% drop, offering investors a cautious‑optimism signal amid market volatility.

VSee Health insider buying signals confidence in a low‑priced stock; directors buy at premium, hinting at potential upside amid telehealth growth.

QuidelOrtho CFO Busky’s recent share purchase signals confidence amid a steep decline—showing insider optimism and potential upside for investors.

Insider selling at Ceribell slows price gains—Parvizi’s 10b5‑1 trades signal cautious optimism; investors eye March conference for a breakout.

ClearPoint Neuro insider buying signals rising confidence: COO, CEO, and CFO all buying RSUs, hinting at undervalued shares and future upside.

Daniel Asher’s surge of insider buying at Ekso Bionics shows confidence in its exoskeleton tech—could this boost the stock’s long‑term upside?

Delcath Systems insider buying spree: executives buy 84k+ shares via options and RSUs, hinting at confidence in future liver‑cancer product prospects and potential share rally.